NEW YORK, Dec. 9, 2015 /PRNewswire/ -- The Law Offices of Vincent Wong are investigating HeartWare International Inc. (NASDAQGS: HTWR) in relation to possible violations of federal securities laws.
Click here to learn about the case: http://docs.wongesq.com/HTWR-Info-Request-Form-1018. There is no cost or obligation to you.
On October 13, 2015, HeartWare announced that the company may not reinitiate enrollment in its MVAD heart pump clinical trials in November 2015, as previously announced. On the announcement of this news, the share price of HeartWare stock has plunged as much as $7.63 per share, or more than 17%, during intraday trading from its October 12, 2015 closing price of $44.03 to trade under $37.00 per share on October 13, 2015. To obtain additional information, contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/HTWR-Info-Request-Form-1018.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE The Law Offices of Vincent Wong